INTRODUCTION: While prone positioning (PP) has been shown to improve patient survival in moderate to severe acute respiratory distress syndrome (ARDS) patients, the rate of application of PP in clinical practice still appears low.AIM: This study aimed to determine the prevalence of use of PP in ARDS patients (primary endpoint), the physiological effects of PP, and the reasons for not using it (secondary endpoints).METHODS: The APRONET study was a prospective international 1-day prevalence study performed four times in April, July, and October 2016 and January 2017. On each study day, investigators in each ICU had to screen every patient. For patients with ARDS, use of PP, gas exchange, ventilator settings and plateau pressure (Pplat) were recorded before and at the end of the PP session. Complications of PP and reasons for not using PP were also documented. Values are presented as median (1st-3rd quartiles).RESULTS: Over the study period, 6723 patients were screened in 141 ICUs from 20 countries (77% of the ICUs were European), of whom 735 had ARDS and were analyzed. Overall 101 ARDS patients had at least one session of PP (13.7%), with no differences among the 4 study days. The rate of PP use was 5.9% (11/187), 10.3% (41/399) and 32.9% (49/149) in mild, moderate and severe ARDS, respectively (P = 0.0001). The duration of the first PP session was 18 (16-23) hours. Measured with the patient in the supine position before and at the end of the first PP session, PaO2/FIO2 increased from 101 (76-136) to 171 (118-220) mmHg (P = 0.0001) driving pressure decreased from 14 [11-17] to 13 [10-16] cmH2O (P = 0.001), and Pplat decreased from 26 [23-29] to 25 [23-28] cmH2O (P = 0.04). The most prevalent reason for not using PP (64.3%) was that hypoxemia was not considered sufficiently severe. Complications were reported in 12 patients (11.9%) in whom PP was used (pressure sores in five, hypoxemia in two, endotracheal tube-related in two ocular in two, and a transient increase in intracranial pressure in one).CONCLUSIONS: In conclusion, this prospective international prevalence study found that PP was used in 32.9% of patients with severe ARDS, and was associated with low complication rates, significant increase in oxygenation and a significant decrease in driving pressure.
PURPOSE: We investigated changes in ARDS severity and associations with outcome in COVID-19 ARDS patients.METHODS: We compared outcomes in patients with ARDS classified as 'mild', 'moderate' or 'severe' at calendar day 1, and after reclassification at calendar day 2. The primary endpoint was 28-day mortality. We also identified which ventilatory parameters had an association with presence of severe ARDS at day 2. We repeated the analysis for reclassification at calendar day 4.RESULTS: Of 895 patients, 8.5%, 60.1% and 31.4% had mild, moderate and severe ARDS at day 1. These proportions were 13.5%, 72.6% and 13.9% at day 2. 28-day mortality was 25.3%, 31.3% and 32.0% in patients with mild, moderate and severe ARDS at day 1 (p = 0.537), compared to 28.6%, 29.2% and 44.3% in patients reclassified at day 2 (p = 0.005). No ventilatory parameter had an independent association with presence of severe ARDS at day 2. Findings were not different reclassifying at day 4.CONCLUSIONS: In this cohort of COVID-19 patients, ARDS severity and mortality between severity classes changed substantially over the first 4 days of ventilation. These findings are important, as reclassification could help identify target patients that may benefit from alternative approaches.
MULTIFILE
BACKGROUND: Estimates for dead space ventilation have been shown to be independently associated with an increased risk of mortality in the acute respiratory distress syndrome and small case series of COVID-19-related ARDS.METHODS: Secondary analysis from the PRoVENT-COVID study. The PRoVENT-COVID is a national, multicenter, retrospective observational study done at 22 intensive care units in the Netherlands. Consecutive patients aged at least 18 years were eligible for participation if they had received invasive ventilation for COVID-19 at a participating ICU during the first month of the national outbreak in the Netherlands. The aim was to quantify the dynamics and determine the prognostic value of surrogate markers of wasted ventilation in patients with COVID-19-related ARDS.RESULTS: A total of 927 consecutive patients admitted with COVID-19-related ARDS were included in this study. Estimations of wasted ventilation such as the estimated dead space fraction (by Harris-Benedict and direct method) and ventilatory ratio were significantly higher in non-survivors than survivors at baseline and during the following days of mechanical ventilation (p < 0.001). The end-tidal-to-arterial PCO2 ratio was lower in non-survivors than in survivors (p < 0.001). As ARDS severity increased, mortality increased with successive tertiles of dead space fraction by Harris-Benedict and by direct estimation, and with an increase in the VR. The same trend was observed with decreased levels in the tertiles for the end-tidal-to-arterial PCO2 ratio. After adjustment for a base risk model that included chronic comorbidities and ventilation- and oxygenation-parameters, none of the dead space estimates measured at the start of ventilation or the following days were significantly associated with 28-day mortality.CONCLUSIONS: There is significant impairment of ventilation in the early course of COVID-19-related ARDS but quantification of this impairment does not add prognostic information when added to a baseline risk model.TRIAL REGISTRATION: ISRCTN04346342. Registered 15 April 2020. Retrospectively registered.
MULTIFILE
Patiëntdata uit vragenlijsten, fysieke testen en ‘wearables’ hebben veel potentie om fysiotherapie-behandelingen te personaliseren (zogeheten ‘datagedragen’ zorg) en gedeelde besluitvorming tussen fysiotherapeut en patiënt te faciliteren. Hiermee kan fysiotherapie mogelijk doelmatiger en effectiever worden. Veel fysiotherapeuten en hun patiënten zien echter nauwelijks meerwaarde in het verzamelen van patiëntdata, maar vooral toegenomen administratieve last. In de bestaande landelijke databases krijgen fysiotherapeuten en hun patiënten de door hen zelf verzamelde patiëntdata via een online dashboard weliswaar teruggekoppeld, maar op een weinig betekenisvolle manier doordat het dashboard primair gericht is op wensen van externe partijen (zoals zorgverzekeraars). Door gebruik te maken van technologische innovaties zoals gepersonaliseerde datavisualisaties op basis van geavanceerde data science analyses kunnen patiëntdata betekenisvoller teruggekoppeld en ingezet worden. Wij zetten technologie dus in om ‘datagedragen’, gepersonaliseerde zorg, in dit geval binnen de fysiotherapie, een stap dichterbij te brengen. De kennis opgedaan in de project is tevens relevant voor andere zorgberoepen. In dit KIEM-project worden eerst wensen van eindgebruikers, bestaande succesvolle datavisualisaties en de hiervoor vereiste data science analyses geïnventariseerd (werkpakket 1: inventarisatie). Op basis hiervan worden meerdere prototypes van inzichtelijke datavisualisaties ontwikkeld (bijvoorbeeld visualisatie van patiëntscores in vergelijking met (beoogde) normscores, of van voorspelling van verwacht herstel op basis van data van vergelijkbare eerdere patiënten). Middels focusgroepinterviews met fysiotherapeuten en patiënten worden hieruit de meest kansrijke (maximaal 5) prototypes geselecteerd. Voor deze geselecteerde prototypes worden vervolgens de vereiste data-analyses ontwikkeld die de datavisualisaties op de dashboards van de landelijke databases mogelijk maken (werkpakket 2: prototypes en data-analyses). In kleine pilots worden deze datavisualisaties door eindgebruikers toegepast in de praktijk om te bepalen of ze daadwerkelijk aan hun wensen voldoen (werkpakket 3: pilots). Uit dit 1-jarige project kan een groot vervolgonderzoek ‘ontkiemen’ naar het effect van betekenisvolle datavisualisaties op de uitkomsten van zorg.
In this proposal, a consortium of knowledge institutes (wo, hbo) and industry aims to carry out the chemical re/upcycling of polyamides and polyurethanes by means of an ammonolysis, a depolymerisation reaction using ammonia (NH3). The products obtained are then purified from impurities and by-products, and in the case of polyurethanes, the amines obtained are reused for resynthesis of the polymer. In the depolymerisation of polyamides, the purified amides are converted to the corresponding amines by (in situ) hydrogenation or a Hofmann rearrangement, thereby forming new sources of amine. Alternatively, the amides are hydrolysed toward the corresponding carboxylic acids and reused in the repolymerisation towards polyamides. The above cycles are particularly suitable for end-of-life plastic streams from sorting installations that are not suitable for mechanical/chemical recycling. Any loss of material is compensated for by synthesis of amines from (mixtures of) end-of-life plastics and biomass (organic waste streams) and from end-of-life polyesters (ammonolysis). The ammonia required for depolymerisation can be synthesised from green hydrogen (Haber-Bosch process).By closing carbon cycles (high carbon efficiency) and supplementing the amines needed for the chain from biomass and end-of-life plastics, a significant CO2 saving is achieved as well as reduction in material input and waste. The research will focus on a number of specific industrially relevant cases/chains and will result in economically, ecologically (including safety) and socially acceptable routes for recycling polyamides and polyurethanes. Commercialisation of the results obtained are foreseen by the companies involved (a.o. Teijin and Covestro). Furthermore, as our project will result in a wide variety of new and drop-in (di)amines from sustainable sources, it will increase the attractiveness to use these sustainable monomers for currently prepared and new polyamides and polyurethanes. Also other market applications (pharma, fine chemicals, coatings, electronics, etc.) are foreseen for the sustainable amines synthesized within our proposition.
The transition towards an economy of wellbeing is complex, systemic, dynamic and uncertain. Individuals and organizations struggle to connect with and embrace their changing context. They need to create a mindset for the emergence of a culture of economic well-being. This requires a paradigm shift in the way reality is constructed. This emergence begins with the mindset of each individual, starting bottom-up. A mindset of economic well-being is built using agency, freedom, and responsibility to understand personal values, the multi-identity self, the mental models, and the individual context. A culture is created by waving individual mindsets together and allowing shared values, and new stories for their joint context to emerge. It is from this place of connection with the self and the other, that individuals' intrinsic motivation to act is found to engage in the transitions towards an economy of well-being. This project explores this theoretical framework further. Businesses play a key role in the transition toward an economy of well-being; they are instrumental in generating multiple types of value and redefining growth. They are key in the creation of the resilient world needed to respond to the complex and uncertain of our era. Varta-Valorisatielab, De-Kleine-Aarde, and Het Groene Brein are frontrunner organizations that understand their impact and influence. They are making bold strategic choices to lead their organizations towards an economy of well-being. Unfortunately, they often experience resistance from stakeholders. To address this resistance, the consortium in the proposal seeks to answer the research question: How can individuals who connect with their multi-identity-self, (via personal values, mental models, and personal context) develop a mindset of well-being that enables them to better connect with their stakeholders (the other) and together address the transitional needs of their collective context for the emergence of a culture of the economy of wellbeing?
